Literature DB >> 1930328

Joint destruction in arthritis: metalloproteinases in the spotlight.

C E Brinckerhoff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1930328     DOI： 10.1002/art.1780340902

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  23 in total

Review 1.  Matrix metalloproteinase inhibitors in rheumatic diseases.

Authors:  D R Close
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Proteolytic mechanisms of cartilage breakdown: a target for arthritis therapy?

Authors:  D J Buttle; H Bramwell; A P Hollander
Journal:  Clin Mol Pathol       Date:  1995-08

Review 3.  Cytokine therapy in rheumatoid arthritis.

Authors:  J Hermann; M Walmsley; F M Brennan
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Interleukin 13 blocks the release of collagen from bovine nasal cartilage treated with proinflammatory cytokines.

Authors:  C S Cleaver; A D Rowan; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

5.  Esculetin inhibits cartilage resorption induced by interleukin 1alpha in combination with oncostatin M.

Authors:  S Elliott; A D Rowan; S Carrère; P Koshy; J B Catterall; T E Cawston
Journal:  Ann Rheum Dis       Date:  2001-02       Impact factor: 19.103

6.  Blocking cartilage destruction with metalloproteinase inhibitors: a valid therapeutic target?

Authors:  T Cawston
Journal:  Ann Rheum Dis       Date:  1993-11       Impact factor: 19.103

7.  Cathepsin k is a critical protease in synovial fibroblast-mediated collagen degradation.

Authors:  W S Hou; Z Li; R E Gordon; K Chan; M J Klein; R Levy; M Keysser; G Keyszer; D Brömme
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

8.  Detection of Luse bodies, spiralled collagen, dysplastic collagen, and intracellular collagen in rheumatoid connective tissues: an electron microscopic study.

Authors:  M F Neurath
Journal:  Ann Rheum Dis       Date:  1993-04       Impact factor: 19.103

9.  Measurement of soluble Fcgamma receptor type IIIa derived from macrophages in plasma: increase in patients with rheumatoid arthritis.

Authors:  M Masuda; T Morimoto; S Kobatake; N Nishimura; K Nakamoto; X H Dong; Y Komiyama; R Ogawa; H Takahashi
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

Review 10.  Cathepsin K inhibitors for osteoporosis and potential off-target effects.

Authors:  Dieter Brömme; Fabien Lecaille
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.